James R Neal is of Akari Therapeutics Plc. Currently has a direct ownership of 24.2 Million shares of AKTX, which is worth approximately $24.2 Million. The most recent transaction as insider was on Dec 23, 2024, when has been sold 2,000,000 shares (Ordinary shares, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.2M
n/a 3M change
n/a 12M change
Total Value Held $24.2 Million

James R Neal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 23 2024
BUY
Grant, award, or other acquisition
-
2,000,000 Added 7.63%
24,216,000 Ordinary shares, par v...

Also insider at

XOMA
XOMA Corp Healthcare
PALI
PALISADE BIO, INC. Healthcare
PCSA
Processa Pharmaceuticals, Inc. Healthcare
IGNYU
Ignyte Acquisition Corp. Financial Services
JRN

James R Neal

Emeryville, CA

Track Institutional and Insider Activities on AKTX

Follow Akari Therapeutics Plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKTX shares.

Notify only if

Insider Trading

Get notified when an Akari Therapeutics PLC insider buys or sells AKTX shares.

Notify only if

News

Receive news related to Akari Therapeutics Plc

Track Activities on AKTX